本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

2.15
+0.12005.91%
成交量:215.43萬
成交額:466.67萬
市值:7.42億
市盈率:-3.30
高:2.21
開:2.05
低:2.05
收:2.03
52周最高:4.46
52周最低:1.04
股本:3.45億
流通股本:2.67億
量比:1.07
換手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率:-42.39%
總資產收益率:-22.08%
市淨率:1.70
市盈率(LYR):-2.48

資料載入中...

2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/22

重要事件披露

Form 8-K - Current report
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

重要事件披露

Form 8-K - Current report
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities